Abstract
The positive effect of reperfusion after ST-elevation myocardial infarction (STEMI) can be reduced by ischemic/reperfusion (I/R) injury.Mannose-binding-lectin (MBL) and soluble C5b-9 (membrane-attack-complex) are involved in complement-driven cell lysis and may play a role in human myocardial I/R injury. We evaluated the potential association between MBL and sC5b-9 in plasma and subsequent cardiac dysfunction in patients with STEMI treated with primary percutaneous coronary intervention (pPCI).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | The Journal of invasive cardiology |
| Vol/bind | 21 |
| Udgave nummer | 1 |
| Sider (fra-til) | 13-9 |
| Antal sider | 7 |
| Status | Udgivet - 1 jan. 2009 |